Glimepiride (GL) is an oral hypoglycaemic agent with compromised solubility. The present work is intended to improve the solubility of this drug by formation of binary eutectic mixtures.
No takes yet. Share an insight, caveat, or question.
S. J. Gill (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: